These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9060693)

  • 21. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
    Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
    J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the Epstein-Barr viral immediate early BRLF1 promoter through a distal NF1 site.
    Glaser G; Vogel M; Wolf H; Niller HH
    Arch Virol; 1998; 143(10):1967-83. PubMed ID: 9856084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.
    Ragoczy T; Heston L; Miller G
    J Virol; 1998 Oct; 72(10):7978-84. PubMed ID: 9733836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC; Thorley-Lawson DA
    J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
    Bhende PM; Seaman WT; Delecluse HJ; Kenney SC
    J Virol; 2005 Jun; 79(12):7338-48. PubMed ID: 15919888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
    Furlong EE; Rein T; Martin F
    Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
    Sista ND; Pagano JS; Liao W; Kenney S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.
    Zalani S; Holley-Guthrie E; Kenney S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9194-9. PubMed ID: 8799177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter.
    Bell A; Skinner J; Kirby H; Rickinson A
    Virology; 1998 Dec; 252(1):149-61. PubMed ID: 9875325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta.
    Hung CC; Kuo CW; Wang WH; Chang TH; Chang PJ; Chang LK; Liu ST
    J Gen Virol; 2015 Sep; 96(9):2855-2866. PubMed ID: 26297580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.
    Swenson JJ; Mauser AE; Kaufmann WK; Kenney SC
    J Virol; 1999 Aug; 73(8):6540-50. PubMed ID: 10400750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.
    MacCallum P; Karimi L; Nicholson LJ
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1501-1512. PubMed ID: 10374969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1.
    Breslin MB; Vedeckis WV
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):369-81. PubMed ID: 10030686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
    Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
    Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
    J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.
    Schwarzmann F; Prang N; Reichelt B; Rinkes B; Haist S; Marschall M; Wolf H
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1999-2006. PubMed ID: 8046403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
    Holley-Guthrie EA; Quinlivan EB; Mar EC; Kenney S
    J Virol; 1990 Aug; 64(8):3753-9. PubMed ID: 2164595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.